DOJ Launches Novartis Probe Into Gilenya Illegal Marketing
The Justice Department is investigating Novartis over potential kickbacks related to sales of Gilenya.
The Justice Department is investigating Novartis over potential kickbacks related to sales of Gilenya.
The federal government has filed a lawsuit against Novartis Pharmaceuticals this week, claiming that the pharmaceutical company engaged in an illegal kickback scheme to sell its kidney transplant drug Myfortic.…
The FDA is requiring new warnings on several immunosuppressant drugs designed to prevent renal transplant patients from rejecting new kidneys. The new labeling will warn users of potential side effects…
Roche and Novartis have added warnings to their organ transplant medications, CellCept and Myfortic, indicating an association with Progressive Multifocal Leukoencephalopathy, a rare and potentially fatal neurological condition.
In November 2007, the FDA added a black boxed warning about possible Myfortic side effects which could increase the risk of birth defects and malformations. According to reports, pregnant women…
On Friday, the FDA posted an alert on their website to provide additional information to doctors about the possible risk of miscarriages and birth defects associated with the use of…